Paul R Kirchgraber - Net Worth and Insider Trading
Paul R Kirchgraber Net Worth
The estimated net worth of Paul R Kirchgraber is at least $3 Million dollars as of 2024-11-11. Paul R Kirchgraber is the CEO, Covance Drug Development of Labcorp Holdings Inc and owns about 12,946 shares of Labcorp Holdings Inc (LH) stock worth over $3 Million. Details can be seen in Paul R Kirchgraber's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul R Kirchgraber has not made any transactions after 2023-05-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Paul R Kirchgraber
Paul R Kirchgraber Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul R Kirchgraber owns 1 companies in total, including Labcorp Holdings Inc (LH) .
Click here to see the complete history of Paul R Kirchgraber’s form 4 insider trades.
Insider Ownership Summary of Paul R Kirchgraber
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LH | Labcorp Holdings Inc | 2023-05-19 | CEO & Covance Drug Development |
Paul R Kirchgraber Latest Holdings Summary
Paul R Kirchgraber currently owns a total of 1 stock. Paul R Kirchgraber owns 12,946 shares of Labcorp Holdings Inc (LH) as of May 19, 2023, with a value of $3 Million.
Latest Holdings of Paul R Kirchgraber
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LH | Labcorp Holdings Inc | 2023-05-19 | 12,946 | 243.92 | 3,157,788 |
Holding Weightings of Paul R Kirchgraber
Paul R Kirchgraber Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul R Kirchgraber has made a total of 3 transactions in Labcorp Holdings Inc (LH) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Labcorp Holdings Inc is the sale of 4,300 shares on May 19, 2023, which brought Paul R Kirchgraber around $932,713.
Insider Trading History of Paul R Kirchgraber
- 1
Paul R Kirchgraber Trading Performance
Paul R Kirchgraber Ownership Network
Ownership Network List of Paul R Kirchgraber
Ownership Network Relation of Paul R Kirchgraber
Paul R Kirchgraber Owned Company Details
What does Labcorp Holdings Inc do?
Who are the key executives at Labcorp Holdings Inc?
Paul R Kirchgraber is the CEO & Covance Drug Development of Labcorp Holdings Inc. Other key executives at Labcorp Holdings Inc include SVP & Global General Counsel Van Der Vaart Sandra D , Chief Financial Officer & EVP Glenn A Eisenberg , and SVP & Chief Information Officer Lance Berberian .
Labcorp Holdings Inc (LH) Insider Trades Summary
Over the past 18 months, Paul R Kirchgraber made 1 insider transaction in Labcorp Holdings Inc (LH) with a net sale of 4,300. Other recent insider transactions involving Labcorp Holdings Inc (LH) include a net sale of 8,454 shares made by Van Der Vaart Sandra D , a net sale of 7,500 shares made by Kerrii B Anderson , and a net sale of 13,025 shares made by Mark S Schroeder .
In summary, during the past 3 months, insiders sold 18,000 shares of Labcorp Holdings Inc (LH) in total and bought 0 shares, with a net sale of 18,000 shares. During the past 18 months, 67,922 shares of Labcorp Holdings Inc (LH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 67,922 shares.
Labcorp Holdings Inc (LH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Labcorp Holdings Inc Insider Transactions
Paul R Kirchgraber Mailing Address
Above is the net worth, insider trading, and ownership report for Paul R Kirchgraber. You might contact Paul R Kirchgraber via mailing address: 531 South Spring Street, Burlington Nc 27215.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
